Background Traditionally, febrile neutropenia in pediatric oncology patients has been
managed aggressively with hospital admission and intravenous antibiotics. Recent studies …

Background: To describe (1) anticipated health-related quality of life during different
strategies for febrile neutropaenia (FN) management and (2) attributes of those preferring …

Children with cancer treated with chemotherapy are susceptible to bacterial infections and
serious infectious complications. However, fever and neutropenia can also result from other …

Background Febrile neutropenia is a common reason for the hospitalization of pediatric
oncology patients. The initiation of antibiotics and the overall decline in rates of bacteremia …

Background Chemotherapy‐induced neutropenia is a common adverse effect in children
with cancer. Due to the high relative risk of infections and infectious complications, standard …

A comment on this article appears in" Outpatient management of febrile neutropenia:
concerns for the future." J Support Oncol. 2008 May-Jun; 6 (5): 217-8. A comment on this …

As a vast majority of oncologic treatments are being administered in the outpatient setting,
emergency department (ED) physicians are increasingly encountering patients who present …

Background: Procalcitonin and C-reactive-protein are inflammatory markers for sepsis. The
authors evaluated their sensitivity and specificity in pediatric patients with cancer and febrile …

Background Chemotherapy‐induced febrile neutropenia (FN) is traditionally managed with
hospital admission for parenteral antibiotics until neutropenia resolves. Recent studies have …

Introducción: La neutropenia febril (NF) es una complicación frecuente de pacientes
sometidos a quimioterapia (QMT). Su presentación clínica es amplia, desde cuadros leves a …